It's not exactly uplifting, but this article from the Wall Street Journal reports on the fate of the pharmaceutical industry. (We'd say it places it somewhere between "embattled" and "dire.") While a number of blockbuster drugs are coming off patent, fewer and fewer drugs have gone on the market, and -- at least according to pharma execs -- FDA is getting increasingly picky about handing out approvals.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.